Abstract
The use of salmeterol inhaled twice daily compared with either placebo or albuterol gave significant increases in morning and evening peak flow as well as sustained increases in FEV1, and reduced asthma symptoms throughout the day and night. Responses were similar at day 1 and week 12 and no deterioration of asthma control was observed within the study period.
- Copyright © 1995 by the American Academy of Pediatrics
Individual Login
Log in
You will be redirected to aap.org to login or to create your account.
Institutional Login
You may be able to gain access using your login credentials for your institution. Contact your librarian or administrator if you do not have a username and password.
Log in through your institution
If your organization uses OpenAthens, you can log in using your OpenAthens username and password. To check if your institution is supported, please see this list. Contact your library for more details.
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
In this issue
SALMETEROL XINAFOATE AS MAINTENANCE THERAPY COMPARED WITH ALBUTEROL IN PATIENTS WITH ASTHMA
Jump to section
Related Articles
Cited By...
- No citing articles found.